Latham Advises on Hims & Hers Health, Inc.’s Upsized US$350 Million Convertible Senior Notes Offering

Hims & Hers Health, Inc. (NYSE: HIMS), a leading health and wellness platform, has announced the pricing of its offering of US$350 million aggregate principal amount of 0.00% convertible senior notes due 2032 in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933. The offering size was increased from the previously announced offering size of US$300 million aggregate principal amount of notes. The issuance and sale of the notes are scheduled to settle on May 21, 2026, subject to customary closing conditions. Hims & Hers also granted the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional US$52.5 million aggregate principal amount of notes.

Latham & Watkins LLP represents the initial purchasers in the offering with a team led by Stelios Saffos, Global Chair of Latham’s Capital Markets Practice, and partners Tad Freese, member of the firm’s Executive Committee, and Greg Rodgers, Global Vice Chair of the Corporate Department, and partners Brittany Ruiz and Ryan Gold, with associates Andrew Bentz, Jie Lin Nai, Steve Hess, and Helen Zhang. Advice was provided on equity derivatives matters by partner Catherine Lee and counsel Christopher Yu, with associate Henry Lin; and on tax matters by partners Elena Romanova and Grace Lee, with associate Jack Santoro.